All Stories

  1. Probiotic Bacteria from Human Milk Can Alleviate Oral Bovine Casein Sensitization in Juvenile Wistar Rats
  2. Soy Lecithin in High‐Fat Diets Exerts Dual Effects on Adipose Tissue Versus Ileum
  3. Association of carob galactomannans with probiotic bacteria in synbiotic fermented milk and colon targeted-release carrier
  4. Approaches to discern if microbiome associations reflect causation in metabolic and immune disorders
  5. Alteration of microbiota antibody‐mediated immune selection contributes to dysbiosis in inflammatory bowel diseases
  6. Diet-gut microbiota interactions on cardiovascular disease
  7. Beneficial effect of whole-grain wheat on liver fat: a role for the gut microbiota?
  8. Cholesterol-to-Coprostanol Conversion by the Gut Microbiota: What We Know, Suspect, and Ignore
  9. The Epistemic Revolution Induced by Microbiome Studies: An Interdisciplinary View
  10. Interplay Between Exercise and Gut Microbiome in the Context of Human Health and Performance
  11. Tolerogenic Dendritic Cells Shape a Transmissible Gut Microbiota That Protects From Metabolic Diseases
  12. Rapeseed and soy lecithin as vectors of α-linolenic acid: Impacts on adiposity, inflammation and gut microbiota in high-fat fed mice
  13. Fecal Microbiota Transplant from Human to Mice Gives Insights into the Role of the Gut Microbiota in Non-Alcoholic Fatty Liver Disease (NAFLD)
  14. Tolerogenic Dendritic Cells Shape a Transmissible Gut Microbiota that Protects from Metabolic Diseases
  15. Fat‐Shaped Microbiota Affects Lipid Metabolism, Liver Steatosis, and Intestinal Homeostasis in Mice Fed a Low‐Protein Diet
  16. Exploring the Bacterial Impact on Cholesterol Cycle: A Numerical Study
  17. Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease
  18. Murine Genetic Background Overcomes Gut Microbiota Changes to Explain Metabolic Response to High-Fat Diet
  19. The role of microbiota in tissue repair and regeneration
  20. The crosstalk between the gut microbiota and lipids
  21. Fecal microbiome as determinant of the effect of diet on colorectal cancer risk: comparison of meat-based versus pesco-vegetarian diets (the MeaTIc study)
  22. The intestinal microbiota regulates host cholesterol homeostasis
  23. Steatosis and gut microbiota dysbiosis induced by high-fat diet are reversed by 1-week chow diet administration
  24. Fructose malabsorption triggers CCK release through fructose metabolism by gut microbiota
  25. The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD)
  26. Gastrointestinal Tract: Microbial Metabolism of Steroids
  27. Microbial impact on cholesterol and bile acid metabolism: current status and future prospects
  28. Addition of dairy lipids and probiotic Lactobacillus fermentum in infant formula programs gut microbiota and entero-insular axis in adult minipigs
  29. The gut microbiota drives the impact of bile acids and fat source in diet on mouse metabolism
  30. Reduced obesity, diabetes, and steatosis upon cinnamon and grape pomace are associated with changes in gut microbiota and markers of gut barrier
  31. Microbiota, Liver Diseases, and Alcohol
  32. Gut Microbiome and Obesity. How to Prove Causality?
  33. Effect of different microbiota on lipid metabolism, liver steatosis and intestinal homeostasis in mice fed a low-protein diet
  34. The Effects of Weaning Methods on Gut Microbiota Composition and Horse Physiology
  35. Rapid analysis of bile acids in different biological matrices using LC-ESI-MS/MS for the investigation of bile acid transformation by mammalian gut bacteria
  36. High fat diet drives obesity regardless the composition of gut microbiota in mice
  37. Recent Patents on Hypocholesterolemic Therapeutic Strategies: An Update
  38. Gut Microbiota and Obesity
  39. Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease
  40. Gut microbiota and obesity
  41. Microbiote intestinal, cholestérol et maladies cardiovasculaires
  42. P183: Le microbiote intestinal détermine la sévérité de la maladie alcoolique du foie
  43. Les relations entre microbiote intestinal et lipides
  44. Intestinal microbiota in metabolic diseases
  45. O146 INTESTINAL DYSBIOSIS EXPLAINS INTER-INDIVIDUAL DIFFERENCES IN SUSCEPTIBILITY TO ALCOHOLIC LIVER DISEASE
  46. Metabolic Interplay between Gut Bacteria and Their Host
  47. Metabolism of Cholesterol and Bile Acids by the Gut Microbiota
  48. Effect of prebiotic carbohydrates on growth, bile survival and cholesterol uptake abilities of dairy-related bacteria
  49. Short-Chain Fructo-Oligosaccharides Modulate Intestinal Microbiota and Metabolic Parameters of Humanized Gnotobiotic Diet Induced Obesity Mice
  50. Impact du vieillissement sur le microbiote intestinal
  51. Harnessing the beneficial properties of adipogenic microbes for improving human health
  52. Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice
  53. Microbiote intestinal et lipides : impact sur la santé humaine
  54. Calcium alginate-resistant starch mixed gel improved the survival ofBifidobacterium animalissubsp.lactisBb12 andLactobacillus rhamnosusLBRE-LSAS in yogurt and simulated gastrointestinal conditions
  55. 1356 TRANSMISSION OF HUMAN LIVER SENSITIVITY TO ALCOHOL BY INTESTINAL MICROBIOTA
  56. 51 GUT MICROBIOTA TRANSPLANTATION DEMONSTRATES ITS CAUSAL ROLE IN THE DEVELOPMENT OF TYPE 2 DIABETES AND FATTY LIVER
  57. O36 Les FOS modulent la flore intestinale et les paramètres métaboliques chez la souris à flore humaine
  58. O36 Les FOS modulent la flore intestinale et les paramètres métaboliques chez la souris à flore humaine
  59. Arabinoxylans and inulin differentially modulate the mucosal and luminal gut microbiota and mucin-degradation in humanized rats
  60. Le microbiote intestinal: composition et fonctions
  61. Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism
  62. Intestinal microbiota develoment in a gut model
  63. 1149 GUT MICROBIOTA MIGHT BE A KEY FACTOR ON THE SEVERITY OF ACUTE ALCOHOLIC HEPATITIS
  64. GI Bacteria Changes in Animal Models Due to Prebiotics
  65. Characterization of Cecal Microbiota and Response to an Orally Administered Lactobacillus Probiotic Strain in the Broiler Chicken
  66. Bacteroides sp. Strain D8, the First Cholesterol-Reducing Bacterium Isolated from Human Feces
  67. Les fonctions majeures du microbiote intestinal
  68. Correlation between faecal microbial community structure and cholesterol-to-coprostanol conversion in the human gut
  69. Isolates from normal human intestinal flora but not lactic acid bacteria exhibit 7α- and 7β-hydroxysteroid dehydrogenase activities
  70. Epimerization of chenodeoxycholic acid to ursodeoxycholic acid byClostridium baratiiisolated from human feces
  71. Epimerization of chenodeoxycholic acid to ursodeoxycholic acid by Clostridium baratii isolated from human feces
  72. Gnotobiotic rats harboring human intestinal microbiota as a model for studying cholesterol-to-coprostanol conversion
  73. Expression and purification of FtsW and RodA from Streptococcus pneumoniae, two membrane proteins involved in cell division and cell growth, respectively
  74. Membrane Topology of the Streptococcus pneumoniae FtsW Division Protein
  75. Both pH and Carbon Flux Influence the Level of Rubredoxin in Clostridium butyricum
  76. Cloning and Characterization of the Gene Encoding Clostridium butyricum rubredoxin
  77. Distribution of the Rubredoxin Gene Among the Clostridium butyricum Species
  78. Human Haptocorrin in Hepatocellular Carcinoma
  79. Effect of glucose on glycerol metabolism by Clostridium butyricum DSM 5431